We arent gonna get NPV on the current resource because it isnt bigger enough. The money winner was the anomoly. If there is nothing else then CQT will have to do it alone. JMHO.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
